Searchable abstracts of presentations at key conferences in endocrinology

ea0055wa8 | Workshop A: Disorders of the hypothalamus and pituitary (I) | SFEEU2018

Challenges in management of cranial diabetes insipidus in critically ill patient

Uchambally Manjima

Cranial diabetes insipidus in critically ill patient increases the complexity of fluid management. Well patients with cranial diabetes insipidus can drink enough fluid to replace their urine losses driven by their thirst mechanisms. In critically ill patients the thirst response cannot be relied upon. When fluid input is not adequate it results in hypernatremia. Here dextrose, water or hypo-tonic intravenous fluid is used. Complications related to this are high glucose levels,...

ea0086p288 | Thyroid | SFEBES2022

Arterial Thrombus in a Graves thyrotoxicosis - Hyper-coagulable state and Hyperthyroidism

Uchambally Manjima , Pernicova Ida

Hyperthyroidism is not a well-known cause of venous thromboembolism. Hyper-coagulable and hypofibrinolytic states are described in hyperthyroidism. A meta-analysis of 51 studies evaluating the consequence (exogenous and endogenous effect on coagulation, raised thyroid levels were associated with a rise in clotting factor VIII, IX, Von Willebrand factor and fibrinogen. The procoagulant effect noticed in hyperthyroidism facilitated by thyroid hormone receptor beta gene. 40-year-...

ea0074ncc21 | Highlighted Cases | SFENCC2021

Steroid responsive encephalopathy associated with autoimmune graves thyroid disease, a rare presentation

Uchambally Manjima , Nahar Meheroon , Macinerney Ruth

Case History: We describe a case of a 30-year-old female who presented at 8 weeks postpartum with history of altered behaviour, clouding of consciousness and status epilepticus. She had been diagnosed with autoimmune graves thyroid disease and was commenced on carbimazole prior to this episode. She was treated as meningoencephalitis. Also, consideration was given for possibility of thyroid storm and post-partum eclampsia. She was intubated and ventilated, treated with IV acycl...

ea0080p8 | Abstracts | UKINETS2021

A 10 year retrospective review of pulmonary neuroendocrine tumours (PulNETs/Carcinoids) in a european tumour centre of excellence

Uchambally Manjima , Munir Alia , Survana Kim , Finnen John

Introduction: Pulmonary neuroendocrine tumours (pulNETs) histologically encompass: small cell, large cell, typical (TC) and atypical carcinoid (AC). Diffuse idiopathic pulmonary neuroendocrine hyperplasia (DIPNECH) is a very rare condition but potentially progress to pulNET and is associated with MEN. Advances in treatment have modified management, and there have been recommendations to use Ki67 for grading. However there is a paucity of randomized studies.<p class="abstex...

ea0063p843 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Efficacy of somatostatin analogues in managing hypercalcaemia due to PTHrP in a well differentiated metastatic pancreatic neuroendocrine tumour and discussion of modern treatment options: A clinical case

Uchambally Manjima , Munir Alia , Wadsley Jonathan , Lorenz Eleanor

Pancreatic neuroendocrine tumours are rare with an incidence of 5 per million. Of these tumours, 75% maybe hormonally functioning. They carry a better prognosis than adenocarcinoma of the pancreas. Parathyroid Hormone related peptide hypersecretion in PNETs is uncommon and is solely associated with metastatic PNETs. 31 cases are reported of PTH-rPoma in the literature. Here we describe a novel case presenting with cough. A previously well 56-year-old female presented to the ac...